Member Profile mfglola | Latest Posts

HOW are they able to showcase "slow

10/31/2024 9:07:29 PM

(6)

What is a bit strange is that they

10/31/2024 11:20:29 AM

Familial ALS? I'm so sorry. That mu

10/30/2024 8:40:24 AM

Coya yesterday reported their low d

10/30/2024 7:01:05 AM

I would expect academic institution

10/29/2024 8:36:20 PM

(7)

Ohm - do you discount the possibili

10/29/2024 10:54:47 AM

At a townhall in Lancaster PA, Elon

10/28/2024 8:19:27 AM

(13)

A fascinating conversation on ccr5

10/19/2024 6:16:10 PM

(6)

Findings may guide future Parkinson

10/11/2024 12:33:51 PM

Since it is an open label study, it

10/06/2024 2:11:04 PM

(6)

Interesting connection between two

09/29/2024 8:34:15 AM

Pegozafermin received BTD for MASH

09/26/2024 6:05:26 PM

The publication shows that 76% of p

09/24/2024 11:10:02 PM

No, US FDA BTD. https://inventivaph

09/24/2024 10:38:32 PM

Lanifibranor received BTD for these

09/24/2024 9:23:55 PM

So it's a bit counter-intuitive to

09/22/2024 6:25:46 PM

(7)

The PI of the trial, with hindsight

09/12/2024 9:00:54 PM

Stem cells in heart failure with re

09/11/2024 7:38:25 PM

the Pennsylvania Cancer and Regene

09/09/2024 9:16:21 AM

Indeed. Even mainstream media picke

08/29/2024 4:19:13 PM

Restoring hippocampal glucose metab

08/28/2024 8:28:07 AM

(9)

I expect FDA would be interested in

08/26/2024 7:13:09 PM

On a few conference calls, Dr. Reck

08/23/2024 11:27:50 PM

Dr. Recknor had identified Syneos a

08/23/2024 9:37:05 PM

Coya Therapeutics has low dose IL-2

08/20/2024 2:20:39 PM

Accelerated approval is very much a

08/14/2024 9:02:23 AM

(19)

Thanks. I suppose that is good for

08/13/2024 4:20:25 PM

The phase 3 trial of Trifluridine/�

08/13/2024 11:34:21 AM

Seems FDA nixed Agenus' plan for ac

07/19/2024 11:38:19 AM

After our preclinical glioblastoma

07/11/2024 8:49:11 PM

I think that study was focused on p

07/08/2024 4:24:23 PM

Will be interesting to see what kin

07/08/2024 8:13:36 AM

Seems blocking CCL24 reduces inflam

07/01/2024 5:31:28 PM

Feuerstein is associated with Stat

07/01/2024 3:55:33 PM

Let's get some BARDA funding. https

07/01/2024 2:21:16 PM

"But neuroplasticity may also have

06/24/2024 10:34:04 PM

Medicenna is seeking BTD for bizaxo

06/24/2024 3:02:29 PM

Our former SAB member Dr. Paul Edis

06/24/2024 12:19:08 PM

Thanks for pointing this out. In my

06/19/2024 9:46:28 PM

You might check Cognito Therapeutic

06/18/2024 9:05:14 PM

Speaking of documentaries, I just f

06/11/2024 10:58:28 PM

(8)

IBD and ETS2 Was searching whether

06/11/2024 9:00:36 AM

I'd speculate that the Alzheimer's

05/23/2024 8:33:03 AM

(16)

It seems regorafenib is one of the

05/18/2024 3:48:34 PM

After chemo and the mabs, is regora

05/17/2024 8:53:30 AM

Maybe some interest from Bayer?

05/16/2024 8:58:55 PM

Are they resurrecting this trial (N

05/16/2024 8:47:32 PM

Once we publish, maybe we'll start

04/29/2024 3:02:55 PM

I was referring to Cidara's corpora

04/03/2024 1:16:34 PM

Slide 42 of their corporate present

04/03/2024 8:53:51 AM